TNF Pharmaceuticals announced that it has changed its corporate name to Q/C Technologies and will begin trading under the new ticker symbol (QCLS) on Nasdaq, effective as of the market open on Thursday, September 25. Until then, the company’s common stock will continue to trade under its current ticker symbol (TNFA). The company also noted that it continues to evaluate strategic options for its legacy therapeutic programs, isomyosamine and Supera-CBD.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNFA:
- TNF Pharmaceuticals regains compliance with Nasdaq
- TNF Pharmaceuticals Secures $7M in Private Placement
- TNF Pharmaceuticals Enters Licensing Agreement with LightSolver
- PharmaCyte Biotech increases stake in TNF Pharmaceuticals by $3M
- TNF Pharmaceuticals gets rights to LightSolver tech for crypto applications